On Monday, C4 Therapeutics Inc (CCCC) stock saw a modest uptick, ending the day at $6.45 which represents a slight increase of $0.84 or 14.97% from the prior close of $5.61. The stock opened at $5.58 ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on C4 Therapeutics (CCCC – Research Report) today and set a price target of ...

Hebron Christian’s valiant effort came up just short in Friday’s Region 8-AA football championship game against Prince Avenue ...

One person is dead Friday night after a shooting on Neill Avenue in East Nashville. Detectives with the Metro Nashville ...

Revenue exceeded analyst estimates significantly. Earnings per share (EPS) also surpassed analyst estimates by 12%. Looking ...

C4 Therapeutics, Inc. ( (CCCC) ) has released its Q3 earnings. Here is a breakdown of the information C4 Therapeutics, Inc. presented to its ...

C4 Therapeutics (CCCC) delivered earnings and revenue surprises of 12.50% and 158.10%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

This power purchase agreement with Meta contributes to ENGIE closing almost 1 GW of signed PPAs in the U.S. for 2024 (YTD).

WATERTOWN, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation ...

The Wenatchee City Council on Thursday approved a service agreement to replace the city's four million gallon water reservoir ...

SAN DIEGO -- There was a clinically meaningful reduction in proteinuria with iptacopan (Fabhalta), and a confirmed clinical ...

One of the quirks about “The Legend of Zelda” franchise is that the protagonist’s name isn’t in the title. Princess Zelda is the damsel in distress, the person who has ...